In this meta-analysis of randomized controlled trials (generally in adults without known health conditions), nicotinamide mononucleotide did not affect glycemic control or blood lipids.
This Study Summary was published on December 26, 2024.
In this meta-analysis of randomized controlled trials (generally in adults without known health conditions), nicotinamide mononucleotide did not affect glycemic control or blood lipids.
This Study Summary was published on December 26, 2024.
